Anxiolytics and Traditional Mood Stabilizers - N1713


About Course #N1713

Release Date: July 27, 2016

Expiration Date: July 31, 2019

The care of patients with mental health diagnoses is by no means limited to psychiatric facilities or practices. Due to the prevalence of mental illness in the U.S. population, patients taking psychiatric medications are treated in virtually all healthcare settings. Anxiety disorders, as a group, represent the most common form of psychiatric illness, and in turn, anti-anxiety medications are prescribed and dispensed with great frequency. Therefore, it is imperative that nurse practitioners maintain current knowledge of these common psychiatric illnesses and treatments.

This course is designed for nurse practitioners in all settings. The purpose of this course is to provide an overview of the psychiatric pharmacotherapy of anxiety disorders and bipolar disorder. This course provides the learner with essential information on anxiolytic and mood stabilizer medications. Clinical pharmacology and pharmacokinetics are briefly discussed in order to explain the actions of the drugs, their effects on symptoms, their most common side effects, and their most serious adverse reactions. Interactions with other medications and potential for abuse of some drugs are also presented. Learners should be able to apply the material from this course to patient management and teaching scenarios.

This course is an extraction of, and should not be taken in conjunction with, course #N1751, Nursing Psychopharmacology (10 Contact Hours)

About the Author(s)

Charles F. Caley, BS Pharm, PharmD, BCPP, is clinical professor of pharmacy practice at the University of Connecticut School of Pharmacy and is a board-certified psychiatric pharmacist providing clinical and education services at the Institute of Living in Hartford, Connecticut. Dr. Caley received his bachelor of science in pharmacy and PharmD degrees from the University of Rhode Island College of Pharmacy, and then completed a 2-year specialty residency in psychiatric pharmacy at the Institute of Mental Health in Cranston, Rhode Island, and at Eastern State Hospital in Medical Lake, Washington. Dr. Caley is also an active provider of professional services to the psychiatric pharmacy profession. He is a founding member of the College of Psychiatric and Neurologic Pharmacists (CPNP) and served as the organization's president in 2005-2006. He is a past president of the Board of Directors for the CPNP Foundation. Dr. Caley actively generates scholarship centered on psychotropic medications, and he has published in journals of pharmacy, psychiatry, and college health. Additionally, he provides professional education presentations to audiences at the local, regional, and national levels. Currently, Dr. Caley is working with others to transform the practice of pharmacy in Connecticut by being an active provider of comprehensive medication management services and also by leading a national effort to formally organize and recognize the practice efforts of those pharmacists in community mental health pharmacy settings.

Course Disclosures

  • Courses must be completed on or before the expiration date noted in the course description above.
  • You must score 75% or higher on the final exam and complete the course evaluation to pass this course and receive a certificate of completion.
  • Through our review processes, Western Schools ensures that this course content is presented in a balanced, unbiased manner and is free from commercial influence. It is Western Schools' policy not to accept commercial support.
  • All persons involved in the planning and development of this course have disclosed no relevant financial relationships or other conflicts of interest related to the course content.

  • bvseo_sdk, p_sdk, 3.2.0
  • CLOUD, getContent, 155.01ms
  • bvseo-msg: HTTP status code of 404 was returned;